Related Experiment Videos
Pathophysiological background for the use of calcium antagonists
Journal of Cardiovascular Pharmacology
|January 1, 1985
Summary
Blood pressure elevation in essential hypertension is linked to increased total peripheral vascular resistance (TPR), not cardiac output (CO). Calcium antagonists effectively lower blood pressure by reducing TPR and inhibiting norepinephrine-induced vasoconstriction.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
Background:
- Essential hypertension is a complex condition with multifactorial causes.
- Understanding the relationship between blood pressure, vascular resistance, and cardiac output is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the correlation between blood pressure (BP) and total peripheral vascular resistance (TPR) in normotensive and hypertensive humans.
- To elucidate the hypotensive mechanisms of calcium antagonists.
- To examine cardiovascular responses to norepinephrine with and without calcium antagonists.
Main Methods:
- Investigated BP, heart rate (HR), stroke volume (SV), and cardiac output (CO) in normotensive and genetic essential hypertensive humans.
- Administered intravenous calcium antagonists (diltiazem, nifedipine) and norepinephrine.
- Analyzed cardiovascular responses before and after drug administration.
Main Results:
- BP was positively correlated with TPR (r = 0.710, p < 0.001) but not CO.
- Diltiazem lowered BP and TPR; nifedipine lowered BP and TPR while increasing HR, SV, and CO.
- Norepinephrine increased BP and TPR; prior nifedipine administration inhibited this TPR increase, while propranolol did not.
Conclusions:
- Elevated BP in essential hypertension is primarily dependent on alterations in TPR, not CO.
- Arterial vasodilating effects of calcium antagonists reduce TPR and BP.
- Abnormal systemic arterial smooth muscle function may be a primary cause of essential hypertension.